Laboratory Medicine: Advances and challenges

Clinical Biochemistry

Volumn 50, Issue 6, 2017, Pages 251-252

  Delvin, E ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Laboratory Medicine; Next generation sequencing; Proteomics

Indexed keywords

ARTICLE; INFORMATION SYSTEM; INFORMATION TECHNOLOGY; LABORATORY MEDICINE; MEDICAL LITERATURE; MEDICINE; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; PROTEOMICS; CLINICAL LABORATORY SERVICE; ECONOMICS; HEALTH CARE COST; HEALTH IMPACT ASSESSMENT; HIGH THROUGHPUT SEQUENCING; HUMAN; LABORATORY TECHNIQUE; MANPOWER; PROCEDURES; TRENDS;

CLINICAL LABORATORY SERVICES; CLINICAL LABORATORY TECHNIQUES; DIRECT SERVICE COSTS; HEALTH IMPACT ASSESSMENT; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PROTEOMICS;

EID: 85006988840     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2016.11.021     Document Type: Article

References (12)

1. [1] Alkorta-Aranburu, G., Carmody, D., Cheng, Y.W., Nelakuditi, V., Ma, L., Dickens, J.T., Das, S., Greeley, S.A., del Gaudio, D., Phenotypic heterogeneity in monogenic diabetes: the clinical and diagnostic utility of a gene panel-based next-generation sequencing approach. Mol. Genet. Metab. 113:4 (2014), 315–320.
2. [2] Baudin, B., Bruneel, A., Poupon, R., Vaubourdolle, M., Serum proteomic signatures as biomarkers of primary biliary cirrhosis diagnosis and prognosis. Ann. Biol. Clin. (Paris) 74:5 (2016), 607–612.
3. [3] Bersano, A., Zuffardi, O., Pantoni, L., Quaglini, S., Ciccone, R., Vetro, A., Persico, A., Denaro, M.F., Micieli, G., Next generation sequencing for systematic assessment of genetics of small-vessel disease and lacunar stroke. J. Stroke Cerebrovasc. Dis. 24:4 (2015), 759–765.
4. [4] Conrotto, P., Souchelnytskyi, S., Proteomic approaches in biological and medical sciences: principles and applications. Exp. Oncol. 30:3 (2008), 171–180.
5. [5] Delvin, E.E., Editorial. Clin. Biochem. 39:5 (2006), 425–426.
6. [6] Desmedt, C., Voet, T., Sotiriou, C., Campbell, P.J., Next-generation sequencing in breast cancer: first take home messages. Curr. Opin. Oncol. 24:6 (2012), 597–604.
7. [7] Devarajan, P., The use of targeted biomarkers for chronic kidney disease. Adv. Chronic Kidney Dis. 17:6 (2010), 469–479.
8. [8] Guo, Y., Fu, Z., Van Eyk, J.E., A proteomic primer for the clinician. Proc. Am. Thorac. Soc. 4:1 (2007), 9–17.
9. [9] Jiang, S., Wang, Y., Liu, Z., The application of urinary proteomics for the detection of biomarkers of kidney diseases. Adv. Exp. Med. Biol. 845 (2015), 151–165.
10. [10] Lynch, T.J., Bell, D.W., Sordella, R., Gurubhagavatula, S., Okimoto, R.A., Brannigan, B.W., Harris, P.L., Haserlat, S.M., Supko, J.G., Haluska, F.G., Louis, D.N., Christiani, D.C., Settleman, J., Haber, D.A., Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 350:21 (2004), 2129–2139.
11. [11] Margulies, M., Egholm, M., Altman, W.E., Attiya, S., Bader, J.S., Bemben, L.A., Berka, J., Braverman, M.S., Chen, Y.J., Chen, Z., Dewell, S.B., Du, L., Fierro, J.M., Gomes, X.V., Godwin, B.C., He, W., Helgesen, S., Ho, C.H., Irzyk, G.P., Jando, S.C., Alenquer, M.L., Jarvie, T.P., Jirage, K.B., Kim, J.B., Knight, J.R., Lanza, J.R., Leamon, J.H., Lefkowitz, S.M., Lei, M., Li, J., Lohman, K.L., Lu, H., Makhijani, V.B., McDade, K.E., McKenna, M.P., Myers, E.W., Nickerson, E., Nobile, J.R., Plant, R., Puc, B.P., Ronan, M.T., Roth, G.T., Sarkis, G.J., Simons, J.F., Simpson, J.W., Srinivasan, M., Tartaro, K.R., Tomasz, A., Vogt, K.A., Volkmer, G.A., Wang, S.H., Wang, Y., Weiner, M.P., Yu, P., Begley, R.F., Rothberg, J.M., Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:7057 (2005), 376–380.
12. [12] Price, C.P., John, A.S., Christenson, R., Scharnhorst, V., Oellerich, M., Jones, P., Morris, H.A., Leveraging the real value of laboratory medicine with the value proposition. Clin. Chim. Acta 462 (2016), 183–186.